13F-HR - Garda Capital Partners LP (0001666905) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Garda Capital Partners LP.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Garda Capital Partners LP.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Kingdom Financial Group LLC..
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Prospera Financial Services Inc.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by NNS Ltd.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Deseret Mutual Benefit Administrators.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by ELLERSON GROUP INC /ADV.
Caliber has launched tokenized offerings for three new real estate developments and a feeder fund totaling $85 million, enhancing liquidity and management capabilities for investor…
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Aufman Associates Inc.
Creatd appointed Claudia Albelais CFO and Chelsea Pullano to its board ahead of an exchange listing, reflecting strengthened governance and financial operations.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Hudson Canyon Capital Management.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by SMART Wealth LLC.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Jackson Creek Investment Advisors LLC.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Closed-End Fund Advisors, Inc..
JLL Income Property Trust acquired the West Boston Distribution Center for $36 million. The latest investment bolsters its industrial portfolio, which accounts for the largest perc…
The company rejected an unsolicited proposal to purchase Helen of Troy for $37.00 per share. Board members argue this price is undervaluing the firm and say they remain committed t…
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Diversified Portfolios, Inc..
Ensysce Biosciences amended Dr. Lynn Kirkpatrick's employment and title to Chief Operating Officer effective January 1, 2027. Market relevance is null as no financial guidance was …
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by JOHN G ULLMAN & ASSOCIATES INC.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by EverSource Wealth Advisors, LLC.
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by DCF Advisers, LLC.